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Abstract
The United States Pharmacopoeia (USP) Microbial Limits Test and Preservative
Effectiveness Test were validated and completed on an alcohol-free mouthwash using standard
USP recommended microorganisms and selected organisms isolated from the manufacturing
environment. The microbial limits test using environmental isolates was found equivalent to the
USP Microbial Limits Test currently used for release of the product. The preservative
effectiveness test was performed to determine the efficacy of the parabens system against
environmental isolates compared to those recommended in the USP test. In both tests
Pseudomonas aeruginosa isolates exhibited resistance to the preservative system. All other
isolates failed to grow after week one. Temperature studies conducted with environmental
isolates to evaluate sanitation procedures for manufacturing indicated organisms exposed to 70˚C
for ten minutes resulted in at least a seven log reduction in number. Environmental isolates
exposed to 60˚C and 65˚C were found to survive at these elevated temperatures after a ten
minute exposure period.
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Literature Review
The fear of intrinsic microbial contamination began in the late 1970’s with the discovery
of contaminated intravenous products. Also, in the early 1980’s the fear increased with the
discovery of contaminated povodine-iodine solutions. Products of this nature were never
considered for contamination due to their antiseptic or disinfecting properties or the use of a
preservative system in the product. With the discovery of this new source of contamination,
investigations began into the source and the methods of survival of the contaminating
microorganism.
In 1971, Mackel et al. conducted an investigation into intrinsically contaminated infusion
products that led to an epidemic of septicemia. An investigation into the source of the
contamination revealed microorganisms in both of the product manufacturing plants and that the
newly introduced screw-cap closures being used were not effective at keeping the product sterile.
Along with the epidemic strains of Enterobacter cloacae and Enterobacter agglomerans,
Klebsiella pneumoniae, Acinetobacter calcoaceticus, Bacillus species, Pseudomonas species,
Planococcus species, Corynebacterium species, and Staphylococcus epidermidis were also found
at different locations throughout the manufacturing plants. Due to the ability of moisture from
autoclaving procedures to penetrate the new screw-cap and elastomer closures on the product
bottles, contamination of the intravenous fluid could occur easily when used repetitively within
the hospital setting. (Mackel et al., 1975)
In 1980, Craven et al. conducted an investigation into an outbreak of pseudobacteremia
due to contamination of a povidone-iodine solution. The solution was found to be intrinsically
contaminated with Pseudomonas cepacia from the manufacturing process (Craven et al., 1981).
In 1988 another outbreak of bacteremia and pseudobacteremia due to P. cepacia was discovered
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and linked to a blood gas analyzer at the Clinical Center of the National Institutes of Health’s
clinical intensive care unit (Henderson et al., 1988).
In 1983 Berkelman et al. conducted an investigation of a manufacturing plant after
reports of intrinsic contamination of an iodophor solution. In their study a plant inspection was
done along with scanning electron microscopy (SEM) of polyvinyl chloride (PVC) sections of
pipe removed from the manufacturing plant. A batch of the Prepodyne solution was made in the
laboratory using naturally contaminated water. Storage of the product was also replicated in the
laboratory. In their plant inspection, it was found that the water used to manufacture the product
was not filtered or treated before mixing, but in some cases it was heated. The pipes, made of
steel, copper, PVC, or cast iron, were cleaned only between batches of the product. The records
of the plant showed that products found to be contaminated were stored before packaging for
five to eighteen days in the contaminated pipes. This information was key after the scanning
electron microscopy of the interior surfaces of the PVC pipes showed large numbers of bacterial
growth. Figure 1 (modified from Berkelman et al., 1983) shows a SEM of the interior of one of
the PVC pipe sections recovered from the manufacturing facility. In their experiments they were
unable to recover bacteria from the Prepodyne solution made in the laboratory or from
Prepodyne solution that had been incubated for less than 48 hours in sections of the
contaminated PVC pipe. However, Prepodyne solution incubated in the sections of PVC pipe for
48 and 72 hours contained Pseudomonas aeruginosa. The authors determined that the incubation
of the contaminated iodophor solution from this manufacturing plant was due to the extended
period of time the product was held in the contaminated PVC pipes before packaging.
(Berkelman et al., 1983)
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Figure 1. Scanning electron micrograph of the interior surface of a plant PVC pipe used in
the production of the contaminated iodophor solution investigated by Berkelman et al.
(Berkelman et al., 1983).

Anderson and Berkelman extended the study of the previously mentioned contaminated
iodophor solution to understand the survival of the P. aeruginosa in the solution and possible
methods of resistance to the iodophor solution. In this study the solution was challenged with
high numbers of the P. aeruginosa, and survival was determined during each step of the
manufacturing process. Further testing of the PVC pipe was also done to determine the survival
rate of P. aeruginosa. Anderson et al. found that during the production steps of the solution, P.
aeruginosa did not survive after the final step indicating no resistance to the iodophor was
induced during the separate steps of production. Again P. aeruginosa was recovered from a 1:4
dilution of solution incubated in sections of contaminated PVC pipe for up to 168 days. Although
a method of resistance was not determined from these experiments, a method was established for
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further work in this area, and more questions about product safety were raised. (Anderson et al.,
1983)
An investigation of an intrinsically contaminated respiratory therapy solution began after
infants in a special care nursery showed positive cultures of Pseudomonas pickettii. An
investigation of the production facility recovered P. pickettii cultures from four separate
locations in the plant. The contaminated lots were formulated with water that was not passed
through an 83˚C holding tank. The temperature within this holding tank would have been
sufficient to kill the contaminating strain in the respiratory therapy solution according to McNeil
et al. This product was voluntarily recalled after the contamination was discovered. (McNeil et
al., 1985)
In 1985, another intrinsically contaminated commercial respiratory therapy solution
sparked an investigation into the survival of Pseudomonas pickettii under varying environmental
conditions. Anderson et al. studied P. pickettii for heat tolerance, growth at temperature between
15˚C and 42˚C in the saline solution, and also, growth in small and large volumes of the product.
The results indicated that P. pickettii was able to grow well at temperatures between 22˚C and
42˚C but exhibited slower growth at 15˚C. When exposed to elevated temperatures in a water
bath at 50˚, 55˚, 60˚, P. pickettii had a D-value of 26.0, 1.9, and 0.7 minutes respectively. The Dvalue represents the time in minutes required at the given temperatures to reduce the surviving
population of microorganisms 10-fold. When inoculated in a small or large volume of saline
solution, P. pickettii proliferated for 168 hours to a density of 106 colony forming units (cfu)/ml.
(Anderson et al., 1985)
In 1989, cases of Pseudomonas cepacia were found in Texas hospital patients who had
received peritoneal dialysis treatment. The infections were linked to a Clinidine povidone-iodine
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solution being used within the hospital. Cultures of P. cepacia were recovered from three
unopened containers of the solution. An investigation of the manufacturing facility was
conducted, and the product was voluntarily recalled by the company (CDC, 1989).
Anderson et al.,. also, conducted a study to evaluate the prolonged survival of
Pseudomonas cepacia in a povidine-iodine solution in 1990. Samples were taken weekly, and
survival of P. cepacia occurred during twenty-nine weeks of sampling. This was documented as
sixty-eight weeks after the actual manufacturing of the PI solution. Anderson et al. attributed this
survival and fluctuating growth densities to P. cepacia cells being released from the extracellular matrix over time. (Anderson et al., 1990).
In 1990, an antimicrobial solution was investigated for contamination with
Mycobacterium gordonae due to improper water sterilization. Quality control procedures were
reevaluated after this investigation and further testing was done to avoid continuous problems
with intrinsic contamination. (Tokars et al., 1990)
In 1998, the CDC reported the voluntary recall of Kentron Alcohol Free Mouthwash and
Gargle due to intrinsic contamination with Burkholderia cepacia (formerly Pseudomonas
cepacia). Patients from two Arizona hospitals tested positive for B. cepacia after cultures were
taken from their respiratory tracts while intubated or ventilated in the hospitals’ intensive care
units. During the time the patients were in the ICU, they received oral care with the Kentron
mouthwash. In the investigation of the contaminated mouthwash, B. cepacia, Alcaligenes
xylosoxidan, and a member of the Pseudomonas fluorescens group were recovered from
unopened bottles. (JAMA, 1999) Research into the method and source of the contamination,
along with the method of survival of microorganisms in alcohol-free mouthwashes, merits
further investigation and research.
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Introduction
Each year consumers are informed of thousands of products that are recalled for varying
reasons. These products can include food, pharmaceutical products, pet products, children’s toys,
beauty products and others. Each one poses a threat to the consumer and the producer of the
product in some way. Not only do the companies suffer financial loss, as well as, litigation; but
serious and severe side effects can occur if the product reaches the consumer or a clinical setting.
A serious problem with pharmaceutical products can occur during production. Intrinsic
microbial contamination occurs before the product reaches the consumer and could be from the
incoming water, raw materials, manufacturing equipment, or sanitation procedures used in
manufacturing the product. Unfortunately, not all contaminated products are discovered before
they reach the public. In 1998, Alcohol Free Mouthwash and gargle manufactured by Kentron
was found to be intrinsically contaminated with Burkholderia cepacia after two Arizona
hospitals reported positive cultures for the microorganism. All patients that tested positive had
been intubated, ventilated, and received oral care with the Kentron mouthwash. Kentron
voluntarily recalled this mouthwash product (CDC, 1998). In 2005, a Medline Industries, Inc
alcohol-free mouthwash was also voluntarily recalled after suspected B. cepacia contamination.
Again patients that had been intubated and received oral care with the mouthwash prior to onset
of pneumonia tested positive for B. cepacia (CDC, 2005).
The mouthwash used in this study is also an alcohol-free mouthwash that contains a
parabens preservative system. Parabens or p-hydroxybenzoic acid esters can include methyl,
ethyl, propyl, butyl, or benzyl parabens or several of these in combination for increased
preservative effectiveness. Parabens are effective against fungi but less effective against bacteria.
Parabens preservative systems are also less effective against Pseudomonas species (Hugo and
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Russel, 1983). The alcohol-free mouthwash used in this study utilized a parabens preservative
system, was sugar-free, and packaged in four and eight ounce plastic bottles. During the
manufacture of this product, incoming water is chlorinated, run through activated charcoal, and
then run through two sets of ion exchange resins. The water then passes through two sets of
ultraviolet lights and two sets of 0.45 µm filters. The water is then put in mixing kettles through
stainless steel pipes where the raw materials are added and mixed. After the mouthwash is
formulated, it is run through stainless steel pipes to the packaging system to be placed in plastic
bottles. After production of the mouthwash, the mixing kettles are then cleaned with water
through garden hoses with nozzles. These hoses are stored hanging on the wall in various rooms
of the manufacturing plant. This practice unfortunately is believed to have caused the intrinsic
contamination of the mouthwash due to bacterial biofilm accumulation in the hoses and hose
nozzles. Test results from a microbial limits test, conducted prior to the start of this study,
showed contamination with a Pseudomonas aeruginosa. Inspection of incoming water showed
no contamination, and further investigation of the source was conducted. Inspection of the
manufacturing equipment and sanitation equipment revealed biofilms. The environmental
isolates used in this study were recovered from the garden hoses and nozzles used in the various
rooms of the plant for sanitation.
One objective of this study was to compare the United States Pharmacopeia (USP)
Microbial Limits test using the standard USP organisms and the environmental isolates
recovered at the manufacturing facility. The Microbial Limits Test is the most widely used test
for the release of pharmaceuticals. It includes two parts: the estimation of aerobic microbial
count and the demonstration of freedom from the selected microorganisms.
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A second objective was to evaluate the preservative system used in the mouthwash by
comparing the standard United States Pharmacopeia (USP) organisms and the isolates recovered
from the manufacturing environment.
A third objective was to evaluate the survival of the environmental isolates when exposed
to temperature between 60˚C and 70˚C in order to improve the manufacturer’s ability to control
further intrinsic microbial contamination.
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Materials and Methods
Isolation of Environmental Organisms
Garden hoses and their nozzles used in the rinsing of the product formulation tanks were
the source of the environmental isolates used in this study. A paraffin square was placed on one
end of a 12 inch piece of hose or a nozzle and filled with peptone tween-80 solution (Peptone
Tween-80 was prepared by adding 1g peptone and 1mL Tween-80 to 1 L of distilled water. This
medium was autoclaved for 15 minutes at 123˚C) (Difco, Franklin Lakes, NJ). Another square of
paraffin was placed on the other end of the hose or nozzle, and the contents were shaken to
recover the isolates. The peptone tween-80 solution was removed and plated on a tryptic soy
recovery media (TSA was prepared by adding 30 g TSB and 15 g agar to 1 L of distilled water.
This medium was autoclaved for 15 minutes at 123˚C.) (Difco) to isolate the dominate organisms
that were then used in this study. The isolates used were recovered from the following room’s
hoses at the manufacturing facility:
Isolate 1: Garden hose cleaned with isopropyl alcohol from room 2 (Pseudmonas aeruginosa 1)
Isolate 2: Unclean garden hose nozzle from room 3 (P. aeruginosa 2)
Isolate 3: Garden hose cleaned with isopropyl alcohol from room 4 (Pseudomonas species)
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Microbial Limits Test (The United States Pharmacopeia, USP 30/NF 25)
The USP Microbial Limits Test is the most widely used test to assess the microbiological
quality of a manufactured pharmaceutical. The test has two components. The first is to assess the
number of aerobic microorganisms present in a finished manufactured product, and the second is
to certify the sample is free from the selected organisms. Validation of this test method is
required for each pharmaceutical product before this procedure can be utilized.

Preparation of culture media and dispersing solution
1. Tryptic Soy Broth (TSB) (Difco)– TSB was prepared by adding 30 g TSB to 1 L of
distilled water. This medium was then dispensed into sterile culture tubes (10 ml/tube)
and then sterilized for 15 minutes at 123˚C.
2. Tryptic Soy Agar (TSA) (Difco) – TSA was prepared by adding 30 g TSB and 15 g agar
to 1 L of distilled water. This medium was autoclaved for 15 minutes at 123˚C and
dispersed into 100x15 mm petri dishes (25 ml/plate).
3. Peptone Tween-80 (Difco) –Peptone Tween-80 was prepared by adding 1 g peptone and
1mL Tween-80 to 1 L of distilled water. This medium was dispersed into sterile media
bottles (90 ml/bottle) and autoclaved for 15 minutes at 123˚C.
4. D/E Neutralizing Agar (Dey and Engley) (Difco) – D/E was prepared by adding 39 g D/E
broth and 15 g of agar to 1 L of distilled water. This medium was autoclaved for 15
minutes at 123˚C and dispersed into 100 x 15 mm petri dishes (25 ml/plate).
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5. Letheen Broth (Difco) – Letheen broth was prepared by adding 25.7 g letheen broth to
1 L distilled water. This medium was dispersed into sterile media bottles (90 ml/bottle)
and autoclaved for 15 minutes at 123˚C.
6. Selective Media:
a. Pseudomonas Isolation Agar (PIA) (Difco) used in the detection of Psuedomonas
aeruginosa was prepared by adding 4.5 g PIA and 2ml glycerin to 98 ml of
distilled water.
b. Mannitol Salt Agar (MSA) (Difco) used for the detection of Staphlococcus aureus
was prepared by adding 11.1 g MSA to 100 ml of distilled water.
c. MacConkey Agar (Mac) (Difco) used for the detection of Escherichia coli was
prepared by adding 5.0 g Mac to 100 ml distilled water.
d. Salmonella Shigella Agar (SS) (Difco) used for the detection of Salmonella
typhimurium was prepared by adding 6.0 g SS to 100 ml of sterilized distilled
water. This media was not autoclaved.
Unless otherwise indicated, each of the selective media was then sterilized at 123˚C for 15
minutes and dispensed into 18 x 150 mm culture tubes (10 ml/tube) and then slanted.

Preparation of Inoculum
Four organisms, Pseudomonas aeroginosa (ATCC #27853), Staphylococcus aureus
(ATCC #25923), Escherichia coli (ATCC #25922), and Salmonella typhimurium (ATCC
#14028), were individually streaked on TSA medium and grown overnight at 35ºC. Cell
suspensions for each organism were prepared in TSB and diluted to 1:10-6 to achieve a low
inoculum level (< 100 cfu). Dilutions (1:10-5, 1:10-6, and 1:10-7) were also plated on TSA to
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determine the initial inoculum density. These plates were grown overnight at 35ºC and cfu were
counted.
The environmental isolates used in this study were streaked on TSA medium and grown
overnight at 35ºC. A cell suspension was prepared in TSB for each isolate, and dilutions were
made as described previously. Dilutions (1:10-5, 1:10-6, and 1:10-7) were, also, plated on TSA to
determine the initial inoculum level. These organisms were grown overnight at 35ºC and cfu
were counted.

Sample Preparation
The sample preparation (1:10 dilution) was prepared by transferring the alcohol-free
mouthwash (10 ml) into a Peptone Tween-80 dispersing solution (90 ml). This sample was then
aseptically dispersed into sterile 18 x 150 mm culture tubes (10 ml/ tube.)

Validation of the Test Procedure
To estimate the number of viable aerobic microorganisms in the test sample, four sterile
tubes were inoculated with 100 µL of a 1:10-6 dilution of the designated standard organisms and
vortexed to mix the sample. The entire contents of each tube were then passed through separate
0.45 µm membrane filters (Nalgene, Rochester, NY). Each filter was then transferred to the
surface of a D/E neutralizing agar medium and incubated for 48 hours at 35ºC. One sample
remained uninoculated as a control. The number of recovered organisms was assessed by
counting the cfu that developed on the surface of each filter after 48 hours. The objective of this
component of the Microbial Limits Test was to demonstrate that the indicator organisms could
be recovered when present in low numbers.
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To demonstrate that the test product was free from the selected organisms, four sterile
tubes were inoculated with 100 µL of the 1:10-6 dilution of each designated organism. Each tube
was then vortexed, and the entire contents passed through separate 0.45 µm membrane filters
(Nalgene). Each filter was then transferred to a letheen broth enrichment medium (100 ml). An
additional sample remained as an uninoculated control. Samples were incubated at 35ºC for 24
hours and then observed for turbidity. One loopful (10 µL) from each inoculated sample was
then transferred to the appropriate selective medium and incubated at 35ºC for 24 hours. The
uninoculated control sample was sub-cultured onto all four selective media.
This procedure was repeated as described above except environmental isolates replaced
the USP designated isolates. All experiments were completed in duplicate.
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Preservative Effectiveness Test (The United States Pharmacopeia, USP
30/NF 25)
The Preservative Effectiveness Test is a standard test used to determine the efficacy of a
preservative system used in the manufacture of a pharmaceutical product. In this test the product
is inoculated with a high density of selected microorganisms. The USP guidelines stipulate that
bacteria should have no less than a 1.0 log reduction by day fourteen of the test and no increase
from the count at fourteen days. Yeasts should have no increase from the initial count at fourteen
days and twenty-eight days (USP, 2006).

Preparation of Culture Media
1. Tryptic Soy Broth (TSB) (Difco) - TSB was prepared by adding 30 g TSB to 1 L of
distilled water that was dispensed into sterile culture tubes (10 ml/tube) and then
sterilized for 15 minutes at 123˚C.
2. Tryptic Soy Agar (TSA) (Difco) – TSA was prepared by adding 30 g TSB and 15 g agar
to 1 L of distilled water. This medium was autoclaved for 15 minutes at 123˚C and
dispersed into 100 x 15 mm petri dishes (25 ml/plate).
3. Sabouraud Dextrose Agar (SDA) (Difco) – SDA was prepared by adding 30 g of SDA to
1 L of distilled water. This medium was autoclaved for 15 minutes at 123˚C and
dispersed into 100 x 15mm petri dishes (25 ml/plate).
4. Peptone Tween-80 (Difco) – Peptone Tween-80 was prepared by adding 1 g peptone and
1 ml tween 80 to 1 L of distilled water. This medium was dispersed into sterile media
bottles and autoclaved for 15 minutes at 123˚C.
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5. D/E Neutralizing Agar (Difco) – D/E was prepared by adding 39 g D/E broth and 15 g of
agar to 1 L of distilled water. This medium was autoclaved for 15 minutes at 123˚C and
dispersed into 100 x 15 mm petri dishes (25 ml/plate).
6. Saline solution (Hyclone, Logan, UT)– Saline solution was prepared by adding 100 ml
saline solution to 900 ml distilled water. This medium was then sterilized for 15 minutes
at 123˚C.

Preparation of Inoculum
Pseudomonas aeruginosa (ATCC #9027), Staphylococcus aureus (ATCC #6538),
Escherichia coli (ATCC #8739), Candida albicans (ATCC #10231) and Aspergillus niger
(ATCC #16404), were grown overnight from stock culture in 10 ml TSB medium. Following
incubation, Psuedomonas aeruginosa, Staphylococcus aureus, and Escherichia coli were
subcultured onto TSA and grown at 35ºC for 24 hours prior to testing. Candida albicans was
grown at 25ºC on TSA for five days prior to experimentation. Aspergillus niger was subcultured
onto SDA medium and incubated at 25ºC for seven days prior to testing. Suspensions of all
organisms were prepared in sterile saline, and dilutions were prepared using the standard platecount method to estimate the original inoculum density.
The environmental isolates were grown on TSA overnight at 35ºC and a suspension of
each isolate was then prepared in saline. Dilutions were completed to estimate initial inoculum
densities using the standard plate-count method.
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Procedure
Alcohol-free mouthwash (20 ml) was placed in each of five sterile media bottles and
inoculated with 100 µL of the prescribed test organism containing 105 to 106 cfu/ml sample. All
cultures were then incubated at 25ºC. Following incubation at 7, 14, 21, and 28 days, aliquots
(1 ml) of the mouthwash were removed and added to 9 ml of peptone tween-80 in sterile test
tubes. These samples were then passed through separate 0.45 µm membrane filters (Nalgene)
and placed on D/E recovery medium. The recovery media inoculated with Pseudomonas
aeruginosa, Staphylococcu , aureus, and Escherichia coli were incubated at 35ºC for 48 hours.
Candida albicans and Aspergillus niger were incubated at 25ºC for seven days. Survival of
P. aeruginosa isolates in the test product required dilutions (1:10 and 1:100) at each sampling
time.
This test procedure was repeated by replacing the USP designated organisms with the
environmental isolates recovered from the manufacturing environment. All tests were completed
in duplicate.
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Effect of Elevated Temperatures on Survival of Environmental Isolates
Temperature studies were done to assess the ability of the environmental isolates to
survive at elevated temperatures between 60˚C and 70˚C. These studies were undertaken to help
the manufacturer control further intrinsic microbial contamination using heat sanitization.

Preparation of culture media
1. Tryptic Soy Broth (TSB) (Difco) – TSB was prepared by adding 30 g TSB to 1 L of
distilled water that was dispensed into sterile culture tubes (10 ml/tube) and then
sterilized for 15 minutes at 123˚C.
2. Tryptic Soy Agar (TSA) (Difco)– TSA was prepared by adding 30 g TSB and 15 g agar
to 1 L of distilled water. This medium was autoclaved for 15 minutes at 123˚C and
dispersed into 100 x 15 mm petri dishes (25 ml/plate).
3. Saline solution (Hyclone) – Saline solution was prepared by adding 100 ml saline
solution to 900 ml distilled water. This medium was then sterilized for 15 minutes at
123˚C.

Preparation of Inoculum
The environmental isolates were grown overnight on TSA at 35˚C. A cell suspension was
made in TSB, and dilutions were made to determine initial inoculum densities by the standard
plate count method.
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Test Procedure
An aliquot (100 µL) of the original suspension was added to TSB (10 ml) tempered to
60˚C. An aliquot (1 ml) was removed at one, five, and ten minute intervals and placed in 10 ml
TSB. Samples were then filtered through separate 0.45 µm membrane filters (Nalgene) and
placed on surface of tryptic soy agar medium. Cultures were then incubated at 35˚C for 48 hours.
The number of recovered organisms was assessed by counting the number of cfu on the surface
of each membrane filter. This test procedure was repeated for 65˚C and 70˚C and completed in
duplicate for each isolate and temperature. This procedure was also completed replacing the
tryptic soy broth with saline using exposure times of five and ten minutes.
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Results
United States Pharmacopeia Microbial Limits Test
The microbiological quality of the alcohol-free mouthwash was assessed using the
standard USP Microbial Limits Test. The validation of the aerobic plate count method results are
presented in Tables 1 and 3. The results for the validation that the product was free from the USP
designated organisms are presented in Tables 2 and 4. The standard USP methods were
validated, and all designated organisms were recoverable when present in low numbers. The
mouthwash was also certified as free from the designated USP organisms.

Table 1. Validation of the USP Microbial Limits Test with Alcohol-Free Mouthwash, Lot
21021A. Aerobic Plate Count (Replicate 1).
Organism
Pseudomonas aeroginosa
(ATCC #27853)
Staphylococcus aureus
(ATCC #25923)
Escherichia col I
(ATCC #25922)
Salmonella typhimurium
(ATCC #14028)
Uninoculated Control

Initial Inoculum
cfu/100 µL
15

Recovery on D&E Agar
48hrs at 35˚C (cfu/mL)
13

63

52

70

55

69

70

N/A

<10

Table 2. Validation of the Microbial Limits Test with Alcohol-Free Mouthwash, Lot
21021A. Freedom From Selected Organisms (Replicate 1).
Organism
Pseudomonas aeruginosa
Staphylococcus aereus
Escherichia coli
Salmonella typhimurium

Selective
Medium
PIA
MS
MAC
SS

+ Controls
+
+
+
+
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Growth in
Letheen
+
+
+
+

Test Sample
(Uninoculated)
-

Table 3. Validation of the USP Microbial Limits Test with Alcohol-Free Mouthwash, Lot
20475F. Aerobic Plate Count (Replicate 2).
Organism
Pseudomonas aeroginosa
(ATCC #27853)
Staphylococcus aureus
(ATCC #25923)
Escherichia coli
(ATCC #25922)
Salmonella typhimurium
(ATCC #14028)
Uninoculated Control

Initial Inoculum
cfu/100 µL
140

Recovery on D&E Agar
48hrs at 35˚C (cfu/ml)
13

165

52

107

55

123

70

N/A

<10

Table 4. Validation of the Microbial Limits Test with Alcohol-Free Mouthwash, Lot
20475F. Freedom From Selected Organisms (Replicate 2).
Organism
Pseudomonas aeruginosa
Staphylococcus aereus
Escherichia coli
Salmonella typhimurium

Selective
Medium
PIA
MS
MAC
SS

+ Controls
+
+
+
+
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Growth in
Letheen
+
+
+
+

Test Sample
(Uninoculated)
-

Microbial Limits Test Using Environmental Isolates
The microbiological quality of the mouthwash was also assessed by modifying the
Microbial Limits Test with the selected environmental isolates. The results are shown in Tables 5
through 8. The standard USP method was validated for use with the environmental isolates, and
organisms were recoverable when present in low numbers. The mouthwash was also certified
free of the selected environmental isolates.

Table 5. Validation of the USP Microbial Limits Test with Alcohol-Free Mouthwash, Lot
21021A, using selected environmental isolates. Aerobic Plate Count. (Replicate 1).
Organism
Pseudomonas aeruginosa 1
Pseudomonas aeruginosa 2
Pseudomonas sp.
Uninoculated Control

Initial Inoculum
cfu/100 µL
96
59
66
N/A

Recovery on D&E Agar
48hrs at 35˚C (cfu/ml)
90
50
77
<10

Table 6. Validation of the USP Microbial Limits Test with Alcohol-Free Mouthwash, Lot
21021A, using selected environmental isolates. Freedom From Selected Organisms
(Replicate 1).
Organism
P. aeruginosa 1
P. aeruginosa 2
Pseudomonas sp.

Selective
Medium
PIA
PIA
MAC

+ Controls
+
+
+

21

Growth in
Letheen
+
+
+

Test Sample
(Uninoculated)
-

Table 7. Validation of the USP Microbial Limits Test with Alcohol-Free Mouthwash, Lot
21021A, using selected environmental isolates. Aerobic Plate Count. (Replicate 2).
Organism
Pseudomonas aeruginosa 1
Pseudomonas aeruginosa 2
Pseudomonas sp.
Uninoculated Control

Initial Inoculum
cfu/100 µL
150
38
16
N/A

Recovery on D&E Agar
48hrs at 35˚C (cfu/ml)
141
40
20
<10

Table 8. Validation of the USP Microbial Limits Test with Alcohol-Free Mouthwash, Lot
21021A, using selected environmental isolates. Freedom From Selected Organisms
(Replicate 2).
Organism
P. aeruginosa 1
P. aeruginosa 2
Pseudomonas sp.

Selective
Medium
PIA
MSA
MAC

+ Controls
+
+
+
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Growth in
Letheen
+
+
+ (after 48 hrs)

Test Sample
(Uninoculated)
-

United States Pharmacopeia Preservative Effectiveness Test Results
The preservative capacity of the alcohol-free mouthwash was assessed using the standard
USP Preservative Effectiveness Test. In both USP preservative tests, Pseudomonas aeruginosa
showed resistance to the parabens preservative system. At least a 1 log reduction from the initial
inoculum density was observed in both tests by week 1. However, this organism was recoverable
after four weeks in the test product. Staphlococcus aureus, Escherichia coli, Candida albicans,
and Aspergillus niger were not recovered from the inoculated mouthwash after one week
incubation in the test product. (Tables 9 and 10)

Table 9. United States Pharmacopeia Preservative Effectiveness Test with Alcohol-Free
Mouthwash, Lot 20475A. (Replicate 1).

Week 1
Organism
Pseudomonas aeruginosa
(ATCC #9027)
Staphylococcus aureus
(ATCC #6538)
Escherichia coli
(ATCC #8739)
Candida albicans
(ATCC #10231)
Aspergillus niger
(ATCC #16404)
a
0 indicates <20 cfu/ml

Initial
Inoculum
(cfu/ml)
3.40 x 105

Week 2

Week 3

Week 4

(cfu/ml recovered on D/E agar grown at 35ºC)
3.04 x 103 4.96 x 103 2.03 x 103 1.48 x 103

9.05 x 105

0a

0

0

0

8.00 x 105

0

0

0

0

7.50 x 104

0

0

0

0

2.50 x 104

0

0

0

0
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Table 10. United States Pharmacopeia Preservative Effectiveness Test with Alcohol-Free
Mouthwash, Lot 20475A. (Replicate 2).

Week 1
Organism
Pseudomonas aeruginosa
(ATCC #9027)
Staphylococcus aureus
(ATCC #6538)
Escherichia coli
(ATCC #8739)
Candida albicans
(ATCC #10231)
Aspergillus niger
(ATCC #16404)
a
0 indicates <20 cfu/ml

Initial
Inoculum
(cfu/ml)
3.45 x 105

Week 2

Week 3

Week 4

(cfu/ml recovered on D/E agar grown at 35ºC)
9.08 x 103 2.85 x 103 5.90 x 103 1.10 x 104

4.00 x 104

0a

0

0

0

3.20 x 105

0

0

0

0

1.05 x 106

0

0

0

0

3.50 x 104

0

0

0

0
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Environmental Preservative Effectiveness Test Results
The preservative capacity of the alcohol-free mouthwash was also assessed using the
environmental organisms isolated from the manufacturing facility. Pseudomonas aeruginosa
isolates 1 and 2 showed resistance to the parabens preservative system in both environmental
preservative tests. At least a 1 log reduction from the initial inoculum density was observed for
P. aeruginosa 1 while a 2 log reduction from the initial inoculum density was observed for P.
aeruginosa 2. Isolate 3, designated as Pseudomonas species, was not recoverable as of week 1.
(Tables 11 and 12)

Table 11. United States Pharmacopeia Preservative Effectiveness Test with Alcohol-Free
Mouthwash, Lot 20475C, using selected environmental isolates. (Replicate 1).
Number of Surviving Cells (cfu/ml product)a
Time
Pseudomonas species
P. aeruginosa 1
P. aeruginosa 2
6
6
Initial Time
4.75 x 10
1.08 x 10
2.35 x 106
Week 1
TNTCb
TNTC
0c
3
Week 2
4.1 x 10
TNTC
0
Week 3
TNTC
3.24 x 103
0
Week 5
5.00 x 104
1.89 x 103
0
a
colony forming units recovered on D/E Neutralizing Agar after 48 hours at 35˚C.
b
TNTC indicates Too Numerous To Count (>300/ml)
c
0 indicates <20 cfu/ml
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Table12. United States Pharmacopeia Preservative Effectiveness Test with Alcohol-Free
Mouthwash, Lot 20475C, using selected environmental isolates. (Replicate 2).
Number of Surviving Cells (cfu/ml product)a
Time
Pseudomonas species
P. aeruginosa 1
P. aeruginosa 2
6
6
Initial Time
4.80 x 10
2.95 x 10
3.30 x 106
Week 1
7.68 x 104
9.52 x 104
0b
4
4
Week 2
6.76 x 10
6.92 x 10
0
Week 3
6.12 x 104
9.76 x 104
0
4
4
Week 5
6.76 x 10
5.20 x 10
0
a
colony forming units recovered on D/E Neutralizing Agar after 48 hours at 35˚C.
b
0 indicates <20 cfu/ml
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Temperature versus Exposure Time Using Tryptic Soy Broth:
The effect of elevated temperatures on environmental isolates in tryptic soy broth was
assessed at 60˚C, 65˚C, and 70˚C. The results indicate that exposure for 10 minutes at 70˚C
results in at least a 7 log reduction in number for the environmental isolates when tested in
tryptic soy broth. (Tables 14 through 19)

Table 14. Effect of elevated temperature on the survival of Pseudomonas aeruginosa 1 in
tryptic soy broth (Replicate 1).

Temperature
Initial Time
1 min
(˚C)
60
9.6 x 107
TNTCa
65
9.6 x 107
26
7
70
9.6 x 10
0
a
TNTC indicates Too Numerous To Count
b
0 indicates <10 cfu/ml

Number of Surviving Cells (cfu/ml)
5 min
10 min
Log reduction
@ 10 min
b
77
0
7.982
0
0
7.982
0
0
7.982

Table 15. Effect of elevated temperature on the survival of Pseudomonas aeruginosa 1 in
tryptic soy broth (Replicate 2)

Temperature
Initial Time
1 min
(˚C)
60
1.24 x 108
TNTCa
8
65
1.24 x 10
TNTC
70
1.24 x 108
0
a
TNTC indicates Too Numerous To Count
b
0 indicates <10 cfu/ml

Number of Surviving Cells (cfu/ml)
5 min
10 min
Log reduction
@ 10 min
16
17
6.863
b
TNTC
0
8.093
0
0
8.093
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Table 16. Effect of elevated temperature on the survival of Pseudomonas aeruginosa 2 in
tryptic soy broth (Replicate 1)

Temperature
Initial Time
(˚C)
60
6.8 x 107
65
6.8 x 107
70
6.8 x 107
a
0 indicates <10 cfu/ml

1 min
28
29
0

Number of Surviving Cells (cfu/ml)
5 min
10 min
Log reduction
@ 10 min
0a
0
7.833
0
0
7.833
0
0
7.833

Table 17. Effect of elevated temperature on the survival of Pseudomonas aeruginosa 2 in
tryptic soy broth (Replicate 2).

Temperature
Initial Time
1 min
(˚C)
60
8.5 x 107
TNTCa
7
65
8.5 x 10
0b
70
8.5 x 107
0
a
TNTC indicates Too Numerous To Count
b
0 indicates <10 cfu/ml

Number of Surviving Cells (cfu/ml)
5 min
10 min
Log reduction
@ 10 min
TNTC
TNTC
N/A
0
0
7.929
0
0
7.929

Table 18. Effect of elevated temperature on the survival of the Pseudomonas species in
tryptic soy broth (Replicate 1).

Temperature
Initial Time
1 min
(˚C)
60
1.26 x 107
TNTCa
65
1.26 x 107
TNTC
70
1.26 x 107
TNTC
a
TNTC indicates Too Numerous To Count
b
0 indicates <10 cfu/ml

Number of Surviving Cells (cfu/ml)
5 min
10 min
Log reduction
@ 10 min
TNTC
61
5.315
b
0
0
7.100
15
0
7.100
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Table 19. Effect of elevated temperature on the survival of the Pseudomonas species in
tryptic soy broth (Replicate 2).

Temperature
Initial Time
1 min
(˚C)
60
1.95 x 108
TNTCa
8
65
1.95 x 10
TNTC
70
1.95 x 108
TNTC
a
TNTC indicates Too Numerous To Count
b
0 indicates <10 cfu/ml

Number of Surviving Cells (cfu/ml)
5 min
10 min
Log reduction
@ 10 min
TNTC
TNTC
N/A
b
0
0
8.290
0
0
8.290
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Temperature versus Exposure Time Using Saline:
The effect of elevated temperatures and exposure time was also assessed at 60˚C, 65˚C,
and 70˚C using saline. The results indicate that exposure for 10 minutes at 70˚C results in at least
a 7 log reduction in number for the environmental isolates when tested in saline. A replicate of
Pseudomonas aeruginosa 1 could not be completed due to viability of the isolate. (Tables 20
through 24)

Table 20. Effect of elevated temperature on the survival of Pseudomonas aeruginosa 1 in
saline (Replicate 1).
Number of Surviving Cells (cfu/ml)
Temperature
Initial Time
5 min
10 min
Log reduction
(˚C)
@ 10 min
7
a
60
7.2 x 10
TNTC
3
7.380
65
7.2 x 107
3
13
6.743
7
b
70
7.2 x 10
0
0
7.857
a
TNTC indicates Too Numerous To Count
b
0 indicates <10 cfu/ml

Table 21. Effect of elevated temperature on the survival of Pseudomonas aeruginosa 2 in
saline (Replicate 1).

Temperature
Initial Time
(˚C)
60
9.5 x 107
65
9.5 x 107
70
9.5 x 107
a
0 indicates <10 cfu/ml

Number of Surviving Cells (cfu/ml)
5 min
10 min
Log reduction
@ 10 min
15
5
7.279
a
0
1
7.978
3
9
7.023
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Table 22. Effect of elevated temperature on the survival of Pseudomonas aeruginosa 2 in
saline (Replicate 2).

Temperature
Initial Time
(˚C)
60
5.4 x 107
65
5.4 x 107
70
5.4 x 107
a
0 indicates <10 cfu/ml

Number of Surviving Cells (cfu/ml)
5 min
10 min
Log reduction
@ 10 min
0a
7
6.887
0
0
7.732
0
0
7.732

Table 23. Effect of elevated temperature on the survival of the Pseudomonas species in
saline (Replicate 1).
Number of Surviving Cells (cfu/ml)
Temperature
Initial Time
5 min
10 min
Log reduction
(˚C)
@ 10 min
8
a
60
2.50 x 10
TNTC
TNTC
N/A
8
65
2.50 x 10
222
252
5.997
70
2.50 x 108
0b
3
7.921
a
TNTC indicates Too Numerous To Count
b
0 indicates <10 cfu/ml

Table 24. Effect of elevated temperature on the survival of the Pseudomonas species in
saline (Replicate 2).

Temperature
Initial Time
(˚C)
60
5.2 x 107
65
5.2 x 107
70
5.2 x 107
a
0 indicates <10 cfu/ml

Number of Surviving Cells (cfu/ml)
5 min
10 min
Log reduction
@ 10 min
396
57
5.960
6
56
5.968
0a
0
7.716
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Conclusion/Discussion
In this study the environmental isolates recovered from the manufacturing environment
of an alcohol-free mouthwash were investigated because of previous intrinsic microbial
contamination. Due to the severity of the problems associated with intrinsic microbial
contamination of this product and any pharmaceutical product, the source of the contamination
warranted further scrutiny. The limitations of standard USP tests also require consideration when
dealing with pharmaceutical products that can affect public health. USP standard tests are
performed with designated organisms that are unlikely to be the microorganisms present in the
manufacturing environment. When pharmaceutical products are tested, only the standard USP
organisms are used. However, in the actual manufacturing environment the product comes into
contact with many other species of microorganisms, such as the environmental isolates used in
this study. In this study only three environmental isolates were used. However, several other
isolates were found that could have been studied using the same tests to determine their
susceptibility or resistance to the preservative system used.
The first objective of this study was to compare the United States Pharmacopeia (USP)
Microbial Limits test using the standard USP organisms and the environmental isolates
recovered at the manufacturing facility. The test procedure used for the USP Microbial Limits
test was validated using the USP recommended organisms. In both replicates of the USP test, the
alcohol-free mouthwash was certified as free from the designated organisms, and when present
in low numbers, these organisms were recoverable by the standard procedure.
In the Microbial Limits test using the environmental isolates, the standard method was
also validated, and when present in low numbers, the isolates were recoverable. The product was
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also certified as free from Pseudomonas aeruginosa isolates 1 and 2 and isolate 3, a
Pseudomonas species.
The second objective was to evaluate the parabens preservative system used in the
mouthwash. This was done by comparing the standard USP organisms with the isolates
recovered from the manufacturing environment. The United States Pharmacopeia stipulates for a
Preservative Effectiveness test that bacteria should have no less than a 1.0 log reduction by day
fourteen of the test and no increase from the count at fourteen days. Yeasts should have no
increase from the initial count at fourteen days and twenty-eight days (USP, 2006). In the
standard USP test, Pseudomonas aeruginosa (ATCC #9027) exhibited resistant to the parabens
preservative used in the alcohol-free mouthwash. In both replicates at least a two log reduction
was observed for P. aeruginosa by week four of the test. However, all other isolates,
Staphylococcus aureus (ATCC #6538), Escherichia coli (ATCC #8739), Candida Albicans
(ATCC #10231) and Aspergillus niger (ATCC #16404) failed to grow after one week. Although
under the USP stipulations the reduction in number of P. aeruginosa was sufficient, the
resistance the microorganism exhibited is a concern. Parabens are known to be less effective
against Pseudomonas species. This was indicated by the results of these tests (Hugo and Russel,
1983).
The results of the preservative effectiveness test when repeated with the environmental
isolates indicated that P. aeruginosa again displayed a resistance to the preservative system used.
P. aeruginosa isolates 1 and 2 exhibited at least a two log reduction by week four of the test.
However, Isolate 3, a Pseudomonas species failed to grow by week one of the test. Under the
manufacturing conditions, repeated exposure of the Pseudomonas aeruginosa isolates and
Pseudomonas species to the mouthwash could lead to increased resistance over time.
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The third objective of this study was to evaluate the survival of the environmental isolates
when exposed to temperature between 60˚C and 70˚C. These tests were done in order to improve
the manufacturer’s ability to control further intrinsic microbial contamination. Controlling
microbial contamination with elevated temperature rather than chemical agents is better for the
manufacturer. When such agents are used, the manufacturer must demonstrate that no chemical
residue is remaining in the mixing kettles before the actual product is produced. If temperature
can be used with the same result as chemical agents, it would be more beneficial for the
production of these products. These tests were also conducted in both tryptic soy broth (TSB)
and saline to compare the effect of each on the isolates when exposed to the elevated
temperatures. Results indicate that exposure for 10 minutes at 70˚C results in at least a seven log
reduction in number for the environmental isolates when exposed in the presence of TSB. When
exposed for ten minutes in TSB at 65˚C at least a seven log reduction from initial densities was
observed. Results from exposure at 60˚C for ten minutes in TSB were variable and actual
microbial counts, colony forming units, were not determined due to high survival rate. At least a
five log reduction was observed for all three environmental isolates in at least one replicate of the
test.
When the tests were repeated at 70˚C for ten minutes in the presence of saline, at least a
seven log reduction was observed for Pseudomonas aeruginosa 1, Pseudomonas aeruginosa 2,
and the Pseudomonas species. When exposed for ten minutes at 65˚C, at least a six log reduction
in number was observed for the environmental isolates. Exposure at 60˚C for ten minutes also
resulted in at least a five log reduction in number from the initial density levels.
The manufacturers of this mouthwash product and other similar pharmaceutical products
that utilize weak preservative systems should routinely examine their manufacturing facilities to
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help prevent the intrinsic contamination of their products. In the case of the alcohol-free
mouthwash used in this study, sanitization procedures should be reviewed and at least 70˚C
water should be used to rinse the mixing kettles after formulation of the product. Rinsing of the
tanks should also be done for at least ten minutes. However a time period longer than this would
result in a greater kill off of microorganisms. The garden hoses used should regularly be
replaced, and water should be allowed to drain after each use.
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